Proper Name: Botulism Immune Globulin Intravenous (Human)
Manufacturer: California Department of Public Health (CDPH)
- Treatment of infant botulism caused by toxin types A or B in patients below one year of age.
- June 23, 2021 Approval Letter - BabyBIG
- March 29, 2016 Approval Letter - BabyBIG
- Supporting Documents older than three years - BabyBIG
- Dear Healthcare Provider Letter: IMPORTANT CHANGE IN BabyBIG PRESCRIBING INFORMATION - ARCHIVED
Date: September 23, 2013